CIBC World Market’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-546
Closed -$780K 1302
2020
Q4
$780K Buy
546
+117
+27% +$125K ﹤0.01% 820
2020
Q3
$303K Buy
429
+85
+25% +$61.8K ﹤0.01% 959
2020
Q2
$241K Buy
+344
New +$199K ﹤0.01% 976

Other funds holding CDLX

CIBC World Market's CDLX Position: Q1 2021 in Review

CIBC World Market sold out of Cardlytics (CDLX) in Q1 2021, closing a stake of 546 shares — an estimated $780K sold.

CIBC World Market first reported a position in CDLX in Q2 2020 and held it in 3 quarters. The position peaked at $780K in Q4 2020. 204 funds tracked by Wall St. Rank hold CDLX as of Q1 2021.

  • CIBC World Market reported no remaining Cardlytics position as of Q1 2021 after selling out during the quarter.
  • CIBC World Market sold 546 Cardlytics shares in Q1 2021, an estimated $780K.
  • CIBC World Market first reported a position in Cardlytics in Q2 2020 and held it in 3 quarters.
  • CIBC World Market's Cardlytics position peaked at $780K in Q4 2020.
  • 204 funds tracked by Wall St. Rank held Cardlytics as of Q1 2021.

Based on CIBC World Market's 13F filing for Q1 2021, filed 11 May 2021.